https://de.marketscreener.com/kurs/aktie/ASTRAZENECA-PLC-4000930/news/CHMP-empfiehlt-Astrazeneca-Brustkrebsmittel-Lynparza-zur-EU-Zulassung-40831578/?utm_source=telegram&utm_medium=social&utm_campaign=share